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Abstract: introduction: Gabapentin is a second generation anticonvulsant that is effective in the treatment of chronic 
neuropathic pain. Recent data suggests its perioperative administration for attenuation of the hemodynamic response to 
laryngoscopy and intubation. The aim of this study was to compare Oral Gabapentin premedication with no 
premedication in patients undergoing rigid laryngoscopy and endotracheal intubation for General Anaesthesia in terms of 
mean heart rate and mean arterial pressure. 
Methods: This was a randomized controlled trial conducted at Anesthesia Department Holy Family Hospital Rawalpindi. 
Total 100 patients were included in the study and randomly divided into 2 groups. In Group-A patients were given 800 
mg Gabapentin orally and in Group-B patients were not given Gabapentin orally. Baseline parameters (including heart 
rate, Mean Arterial Pressure MAP) were recorded 1 hr. before surgery. Drug selected for given patient was given orally 
with a sip of water. After 1 hr. Data was collected on a standardized Performa and analyzed on SPSS 16 version.  
Results: Mean hear rate in Group-A patients at 1st, 3rd, 5th and at 10th minute was 96.22±11.96, 91.84±11.28, 
84.66±10.98 and 82.10±11.47 respectively. While in Group-B mean heart rate in Group-B patients at 1st, 3rd, 5th and at 
10th minute was 105.70±11.95, 100.42±11.58, 92.18±10.56 and 88.40±9.61 respectively. It was observed that at 1st , 3rd , 
5th and at 10th minute mean heart rate was statistically different in both treatment groups. Mean arterial pressure in 
Group-A patients at 1st, 3rd, 5th and at 10th minute was 103.68±6.55, 100.42±5.63, 96.54±5.72 and 95.04±5.86 
respectively. While in Group-B mean arterial pressure in Group-B patients at 1st, 3rd, 5th and at 10th minute was 
112.40±6.93, 106.60±5.98, 100.90±5.95 and 99.16±5.69 respectively. It was observed that at 1st, 3rd, 5th and at 10th 
minute mean arterial pressure was statistically different in both treatment groups.  
Conclusion: 800 mg oral gabapentin given 1 hour before undergoing rigid laryngoscopy and endotracheal intubation for 
general anesthesia significantly affects mean heart rate and mean arterial pressure at 1st, 3rd, 5th and at 10th minute. 
Keywords: Oral gabapentin, Premedication, Attenuation, Hemodynamic response, Laryngoscopy, Tracheal 
intubation. 
INTRODUCTION 
Airway management via laryngoscopy and tracheal 
intubation is one of most important components of 
general anaesthesia [1]. Laryngoscopy and tracheal 
intubation result in hemodynamic pressor response via 
sympathetic stimulation [2]. This may lead to 
hypertension tachycardia dysrhythmias and in extreme 
cases may lead to myocardial ischemia, infarction and 
cerebral hemorrhage [1, 3-5].  
This pressor response has shown to be associated 
with increased perioperative morbidity and mortality in 
patients with cerebrovascular and cardiovascular 
diseases. Various techniques have been developed to 
attenuate this hemodynamic pressor response. These  
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include deepening of anaesthesia, omitting anticho- 
linergic premedication, lignocaine spray, intravenous 
lignocaine, calcium channel blockers, high dose 
opioids, nitroglycerine ointment, alpha blocker, beta 
blocker and oral clonidine premedication [1, 2, 4-6]. 
Gabapentin is an antiepileptic drug. It acts on central 
nervous system by decreasing synthesis of 
neurotransmitter glutamate and also by binding to 
voltage gated calcium channels. Gabapentin has 
antiallodynic and antihyperalgesic properties and is 
effective in treating neuropathic pain, post herpetic 
neuralgia, complex regional pain syndrome type1, 
malignancy pain and headaches. Studies have shown 
gabapentin to be beneficial in reducing post-operative 
pain scores and opioid requirement, prevention of 
postoperative nausea and vomiting, preoperative 
anxiolysis and reduction of postoperative delirium. It’s 
most recent studies have shown it to be effective in 
attenuating the pressor response of laryngoscopy  
[1, 2, 6-9].  
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Fassoulaki et el. showed gabapentin to be effective 
in stabilizing blood pressure only but has no effect on 
controlling heart rate upon intubation (P=0.001 for 
systolic blood pressure at 0,1,3,5 and 10 min 
respectively as compared to P=0.269 for heart rate) [5].  
Memiş et al. [8] has shown it to be effective in 
controlling both heart rate and blood pressure upon 
intubation. 
So the basic aim of our study is to evaluate the 
effect of gabapentin premedication on both heart rate 
and blood pressure upon laryngoscopy and intubation 
so that gabapentin may be used, in our population, as 
routine premedication for suppression of hemodynamic 
responses to laryngoscopy and intubation during 
general anaesthesia for elective surgeries. 
METHODS 
This randomized control trial study was conducted 
at Holy Family Hospital, Rawalpindi for a period of 6 
months from Jan 2016 to June 2016. A total of 100 
patients were recruited in the study. Sample size = n = 
50 patients in each group. Sampling was done by using 
lottery method.  
SAMPLING SELECTION 
Inclusion Criteria  
• ASA–I (normal healthy patient), II (mild systemic 
disease with no functional limitation). 
• Age: Adults, 20-60 years. 
• Any Elective surgery involving only General 
Anesthesia.  
Exclusion Criteria 
• Emergency procedures. 
• ASA grade III and IV patients with history of 
compromised renal status, cardiac disease (low 
cardiac output states), hypertension, COPD and 
asthma, diabetes 
• Anticipated difficulty in intubation (Mallampatti 
Grade 3 and 4) 
• Hypersensitivity to any drug used,  
• GI disturbance which hinders enteric absorption 
to oral medicine  
• Pregnancy. 
Sampling Technique 
Non probability consecutive sampling 
Duration 
6 months after approval of synopsis from 1-11-2013 
to 31-04-2014. 
Data Collection 
After approval from hospital ethical committee, 100 
patients were recruited according to selection criteria 
and written informed consent was taken. Patients were 
randomly divided in group A and B by lottery method.  
Group A Receive 800 mg Gabapentin orally.  
Group B did not receive Gabapentin.  
Baseline parameters (including heart rate, Mean 
Arterial Pressure MAP) were recorded 1 hr. before 
surgery. Drug selected for given patient was given 
orally with a sip of water. After 1 hr. patient were taken 
to operation theatre. Intravascular access with two 18G 
cannulas was established. Standard monitoring 
including Electrocardiography, pulse oximeter, 
noninvasive blood pressure was attached. Each group 
received lactated ringer solution. Patients were pre-
oxygenated for 3 minutes via face mask and General 
anesthesia was administered with 0.1-0.2 mg/kg 
Nalbuphine, followed by 2mg/kg Propofol, 1-2mg/Kg 
suxamethonium or 0.5 mg/kg Atracurium for induction 
and intubation respectively. After intubation, anesthesia 
was maintained with 60% Nitrous oxide, 40% Oxygen 
and 1.0 - 1.2% Isoflorane. Injection Atracurium 1/5th of 
the induction dose was repeated every 25-30 minutes 
to maintain muscle relaxation. Intubation was 
performed by experienced anesthetist using standard 
Macintosh laryngoscope. Vitals parameters including 
HR and MAP recorded at 1 3 5 10 minutes after 
intubation by anesthesiologist, not knowing the 
premedication received by the patient, on the 
Performa.  
At the end of surgery residual neuromuscular 
blockage was reversed with Neostigmine 0.05 mg kg-1 
and Glycopyrrolate 0.01 mg kg-1 IV. Patients were 
extubated after adequate reversal. A decrease in mean 
arterial pressure greater than 30% below the 
preanaesthetic baseline value and decrease in heart 
rate below45 beats/min was treated by incremental 
doses of ephedrine 4mg IV and atropine 0.3mg IV 
respectively and were excluded from study. 
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Data Analysis 
Data was collected on a standardized Performa and 
analyzed on SPSS 16 version. Continuous variables 
like age, weight, heart rate and Mean Arterial Pressure 
MAP (1 3 5 and 10 min post induction) was expressed 
as mean ± S.D. Categorical variables like gender was 
expressed as frequencies and percentages. Indepen- 
dent sample t-test was used to compare mean heart 
rates and mean arterial pressure in two groups. A p-
value <0.05 was considered statistically significant. 
Effect modifier like age, gender and weight were 
controlled by stratification. 
RESULT 
A total of 100 patients were included in the study. 
Each group contained 50 patients. Mean age of 
patients in Group-A and in Group-B was 31.91±9.72 
and 31.82±9.53 years. Minimum age in Group-A and in 
Group-B was 20 years and maximum age of patients in 
both treatment groups was 57 and 58 years 
respectively. Mean weight of patients in Group-A and in 
Group-B was 64.72±12.28 and 64.54±11.29 Kg. 
In Group-A 21 patients were male and 29 patients 
were females while in Group-B 21 patients were male 
and 29 patients were female. In both treatments 
group’s number of male and female patients was same.  
Table 1: Age (Years) Distribution of Patients in 
Treatment Groups 
 Group-A Group-B Total 
N 50 50 100 
Mean 31.92 31.82 31.87 
SD 9.72 9.53 9.58 
Minimum 20.00 20.00 20 
Maximum 57.00 58.00 58 
Group-A= Gabapentin Orally 
Group-B= Gabapentin orally was not given  
 
Table 2: Weight (KG) of Patients in Treatment Groups 
 Group-A Group-B Total 
N 50 50 100 
Mean 64.72 64.54 64.63 
SD 12.28 11.29 11.74 
Minimum 45.00 45.00 45 
Maximum 96.00 86.00 96 
 
Mean hear rate in Group-A patients at 1st, 3rd, 5th 
and at 10th minute was 96.22±11.96, 91.84±11.28, 
84.66±10.98 and 82.10±11.47 respectively. While in 
Group-B mean heart rate in Group-B patients at 1st, 3rd, 
5th and at 10th minute was 105.70±11.95, 
100.42±11.58, 92.18±10.56 and 88.40±9.61 respec- 
tively. It was observed that at 1st, 3rd, 5th and at 10th 
minute mean heart rate was statistically different in 
both treatment groups. In Group-A patients mean heart 
rate was low as compared to that of Group-B patients. 
Mean arterial pressure in Group-A patients at 1st, 
3rd, 5th and at 10th minute was 103.68±6.55, 
100.42±5.63, 96.54±5.72 and 95.04±5.86 respectively. 
While in Group-B mean arterial pressure in Group-B 
patients at 1st, 3rd, 5th and at 10th minute was 
112.40±6.93, 106.60±5.98, 100.90±5.95 and 
99.16±5.69 respectively. It was observed that at 1st, 3rd, 
5th and at 10th minute mean arterial pressure was 
statistically different in both treatment groups. In 
Group-A patients mean arterial pressure was low as 
compared to that of Group-B patients. 
Table 3; Heart Rate in Treatment Groups at 1ST, 3RD, 5TH 
and 10TH Minute 
 Group Mean ± SD p-value 
Group-A 96.22± 11.96 
Heart Rat-1st Minute 
Group-B 105.70± 11.95 
0.000 
Group-A 91.84± 11.28 Heart Rate-3rd 
Minute Group-B 100.42± 11.58 
0.000 
Group-A 84.66± 10.98 Heart Rate-5th 
Minute Group-B 92.18±10.56 
0.001 
Group-A 82.10±11.47 Heart Rate-10th 
Minute Group-B 88.40±9.61 
0.004 
 
Table 4: Mean Arterial Pressure in Treatment Groups at 
1ST, 3RD, 5TH and 10TH Minute 
 Group Mean ± SD p-value 
Group-A 103.68±6.55 Mean Arterial Pressure 
-1st Minute Group-B 112.40±6.93 
0.000 
Group-A 100.42±5.63 Mean Arterial Pressure 
-3rd Minute Group-B 106.60±5.89 
0.000 
Group-A 96.54±5.72 Mean Arterial Pressure 
-5th Minute Group-B 100.90±5.95 
0.000 
Group-A 95.04±5.86 Mean Arterial Pressure 
-10th Minute Group-B 99.16±5.69 
0.001 
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Heart rate was stratified to see any changes in 
relation to gender of the patients. It was observed that 
at 1st, 3rd, 5th and at 10th minute among male significant 
difference was observed in heart rate in both treatment 
groups. In Group-A male patient’s heart rate was less 
as compared to that of Group-B patients. Similarly 
heart rate was observed for female patients at 1st, 3rd, 
5th and at 10th minute. At 1st and 3rd minute mean heart 
rate was statistically different in both treatment groups 
while at 5th and at 10th minute mean heart rate was 
statistically same in both treatment groups. 
Mean arterial pressure was stratified to see any 
changes in relation to gender of the patients. It was 
observed that at 1st, 3rd, 5th and at 10th minute among 
male & female patients significant difference was 
observed in mean arterial pressure in both treatment 
groups. In Group-A among male & female patients 
mean arterial pressure was less as compared to that of 
Group-B patients at 1st, 3rd, 5th and at 10th minute 
respectively. 
Table 5: Post Stratification of Heart Rate in Relation to 
Gender of Patients 
Male Female 
Heart Rate 
Mean ± SD Mean ± SD 
Group-A 96.00±11.38 96.37±12.55 
1st Minute 
Group-B 108.38±11.59 103.75±12.03 
p-value 0.001 0.026 
Group-A 91.33±10.52 92.20±11.97 
3rd Minute 
Group-B 102.71±11.41 98.75±11.62 
p-value 0.002 0.039 
Group-A 84.09±11.13 85.06±11.04 
5th Minute 
Group-B 95.57±10.29 89.72±10.23 
p-value 0.001 0.102 
Group-A 81.95±11.24 82.20±11.83 
10th Minute 
Group-B 91.38±9.40 86.24±9.33 
p-value 0.005 0.155 
 
Heart rate in both treatment groups was stratified in 
relation to the age of patients. It was observed that in 
Group-A patients heart rate was statistically different in 
age groups at 1st, 3rd, 5th and at 10th minute 
respectively. But in Group-B patients heart rate was not 
statistically significant in relation to the age of the 
patients at 1st, 3rd, 5th and at 10th minute respectively. It 
was also observed that increasing heart rate trend was 
seen in patients in Group-A with the increase in age. 
Mean arterial pressure in both treatment groups was 
observed in relation to the age stratification. On the 
basis of age stratification it was observed that in both 
treatment groups no statistically significant difference 
was present for mean arterial pressure at 1st, 3rd, 5th 
and at 10th minute. 
Table 6: Post Stratification of Mean Arterial Pressure in 
Relation to Gender of Patients 
Male Female 
Mean Arterial Pressure 
Mean ± SD Mean ± SD 
Group-A 102.28±6.52 104.68±6.50 
1st Minute 
Group-B 114.19±6.76 111.10±6.87 
p-value 0.000 0.001 
Group-A 99.14±5.34 101.34±5.75 
3rd Minute 
Group-B 107.33±5.57 106.06±6.15 
p-value 0.000 0.004 
Group-A 95.00±5.48 97.65±5.72 
5th Minute 
Group-B 100.71±6.43 101.03±5.70 
p-value 0.004 0.028 
Group-A 93.33±5.39 96.27±5.96 
10th Minute 
Group-B 98.80±6.26 99.41±5.34 
p-value 0.004 0.039 
DISCUSSION 
Tracheal intubation is a noxious stimulus, tending to 
provoke a marked sympathetic response manifested as 
tachycardia and hypertension which is potentially 
deleterious in some patients. Various agents effectively 
attenuate this response, including anaesthetics, 
analgesics, adrenergic blocking agents and 
vasodilators. This has been a fertile area for clinical 
investigation, spawning numerous studies of the 
various techniques which might be expected to modify 
the haemodynamic response to intubation. Some 
patients unquestionably require careful haemodynamic 
control during induction of anaesthesia and intubation. 
Even a transient hyperdynamic response may cause 
serious complication in patients with symptomatic aortic 
aneurysm, recent myocardial infarction, cerebral 
aneurysm, or intracranial hypertension. Gabapentin, a 
structural analogue of γ-aminobutyric acid, is used 
primarily for the treatment of seizures, neuropathic 
pain, and hot flushes. There are, however, some 
concerns regarding the quality of the research about its 
use to treat migraines, bipolar disorders, acquired 
pendular nystagmus, menopausal symptoms, spasticity 
in multiple sclerosis and uraemic pruritus. Recently, 
gabapentin has been found to be effective in reducing 
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the noxious stimuli to laryngoscopy and intubation, 
thereby attenuating the hemodynamic response. 
Gabapentin acts by decreasing the synthesis of 
neurotransmitter glutamate and by binding to α-2δ 
subunit of voltage dependent calcium channel. Action 
similar to calcium channel blockers may be responsible 
for blunting hemodynamic response to laryngoscopy 
and intubation [10, 11]. 
In our study mean arterial pressure and heart rate 
was significantly reduced in Group-A patients who were 
given 800 mg Gabapentin orally as compared to those 
patients who were not given Gabapentin.  
Vida Ayatollahi et al in his study evaluated the effect 
of 800 mg oral gabapentin on the haemodynamic 
variables during microlaryngoscopic surgery. They 
concluded that 800 mg oral gabapentin given 90 min 
before a procedure attenuates the rise of diastolic 
blood pressure and mean arterial blood pressure in the 
first 15 min after microlaryngoscopy surgery, but has 
no effect on systolic blood pressure or heart rate [12].  
CONCLUSIONS 
Premedication with Gabapentin in a dose of 800 mg 
orally given 1 hour before induction causes significant 
reduction in heart rate and mean arterial pressure till 
10th minutes after laryngoscopy and endotracheal 
intubation for General Anaesthesia thus blunting the 
hemodynamic stress response of laryngoscopy and 
intubation. 
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Table 7: Post Stratification of Heart Rate in Relation to Age of Patients 
 20-30 31-40 41-50 >50 
Time Group Mean ± SD Mean ± SD Mean ± SD Mean ± SD 
p-value 
A 92.61±9.67 96.30±11.75 102.62±13.56 110.00± 15.62 0.029 
1st 
B 105.65±12.63 103.66±11.65 108.71±10.93 108.00±14.14 0.842 
A 87.80±8.56 93.00±11.29 98.62±12.98 103.66±15.30 0.017 
3rd 
B 100.00±12.10 98.91±12.01 103.42±9.58 105.00±14.14 0.806 
A 80.46±8.12 88.23±11.37 89.37±14.47 93.00±10.81 0.033 
5th 
B 91.20±9.88 90.08±12.43 98.42±10.14 97.00±4.24 0.317 
A 77.769±8.81 86.53±11.75 86.00±15.09 90.00±10.00 0.040 
Heart 
Rate 
10th 
B 87.37±9.09 86.33±10.15 95.42±10.30 91.00±1.41 0.190 
 
Table 8: Post Stratification of Mean Arterial Pressure in Relation to Age of Patients 
 20-30 31-40 41-50 >50 
Time Group Mean± SD Mean± SD Mean ± SD Mean± SD 
p-value 
A 101.92±6.22 104.46± 6.56 106.25±6.25 108.66± 8.08 0.170 
1st 
B 113.58±7.01 109.58±5.99 113.00±8.46 110.00±0.00 0.382 
A 98.53±5.24 101.61±5.65 103.25±5.57 104.00±5.29 0.077 
3rd 
B 107.27±5.64 104.33±5.59 107.71±7.91 106.50±2.12 0.505 
A 95.03±5.62 97.69±5.75 98.62±5.95 99.00±4.58 0.274 
5th 
B 100.89±5.67 99.25±4.73 104.28±8.84 99.00±1.41 0.344 
A 93.42± 6.13 96.69±5.08 96.75±6.04 97.33±4.16 0.249 
MAP 
10th 
B 99.06±5.47 97.91±4.67 102.57±7.97 96.00±2.82 0.301 
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